In 2022, which company became the first major insulin manufacturer to voluntarily cap patient out-of-pocket costs at $35 per month for all its insulin products in the US?

The pricing of life-saving medications has long been a contentious issue in the medical industry. In recent years, certain medications have seen dramatic price changes due to policy interventions, public pressure, or market forces. This poll tests your knowledge about a significant pricing policy change that affected millions of patients with diabetes in the United States.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Eli Lilly
Novo Nordisk
Sanofi
Merck